AVBP (ArriVent BioPharma, Inc. Common Stock) Stock Financials & Earnings

AVBPArriVent BioPharma, Inc. Common Stock

Mkt Cap$1B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$166M

EPS (TTM)-$4.47

Free Cash Flow (TTM)-$161M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q1 2026 · Mar 26

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$12M
Q2 23	$0	$0	-$23M
Q3 23	$0	$0	-$17M
Q4 23	$0	$0	-$23M
Q1 24	$0	$0	-$21M
Q2 24	$0	$0	-$26M
Q3 24	$0	$0	-$24M
Q4 24	$0	$0	-$24M
Q1 25	$0	$0	-$67M
Q2 25	$0	$0	-$34M
Q3 25	$0	$0	-$38M
Q4 25	$0	$0	-$39M

Operating Cash Flow

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$0	$0	$0
Q2 23	$158M	$25M	$183M
Q3 23	$141M	$25M	$166M
Q4 23	$150M	$0	$150M
Q1 24	$317M	$0	$317M
Q2 24	$299M	$0	$299M
Q3 24	$283M	$0	$283M
Q4 24	$74M	$145M	$219M
Q1 25	$50M	$126M	$176M
Q2 25	$113M	$123M	$236M
Q3 25	$113M	$188M	$300M
Q4 25	$46M	$267M	$313M

Shares Outstanding

Revenue Per Employee

Revenue / Employee